0 followers
Our scientific initial efforts are aimed at developing drugs that improve the management of proliferative diseases of the bone marrow using an LSD1 inhibitor
Industries
Headquarters
Employees
Links
Hugh Y. Rienhoff, Jr.
Eikon Therapeutics
1 follower
Singularity University
8 followers
REVOLUTION Medicines
5 followers
Halozyme Therapeutics
4 followers
Stemline Therapeutics
3 followers
Celularity
3 followers
Atomwise
3 followers
Karius
2 followers
Pivot Bio
2 followers
Arbutus Biopharma
2 followers
Century Therapeutics
1 follower
Discover companies